Human interleukin-2

DB14865InvestigationalProtein Based Therapies

Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).

Mechanism: Pharmacologically active on Interleukin-2 receptor subunit alpha and Interleukin-2 receptor
Curator reviewed
Also known as: Celmoleukin · hIL2 · IL 2 · IL-2 · IL2

Resolves to

Compound

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

273Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Human interleukin-2, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.